Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana

Figure 5

Incidence of adverse events.

A: Solicited local and general symptoms within the 4-day period after vaccination. Footnote: Error bars represent 95%CI. B: SAEs distribution over time in the total vaccinated cohort. HibMenAC: DTPw-HBV/Hib-MenAC (study vaccine); Control : DTPw-HBV/Hib (control vaccine)

Figure 5

doi: https://doi.org/10.1371/journal.pone.0002159.g005